C
Changchun BCHT Biotechnology Co
SSE:688276
Changchun BCHT Biotechnology Co
SSE:688276
Price:
18.25
CNY
-0.38%
Market Closed
Market Cap:
¥7.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Changchun BCHT Biotechnology Co
SSE:688276
|
CN |
|
ANTA Sports Products Ltd
OTC:ANPDY
|
CN |
|
Borqs Technologies Inc
OTC:BRQSF
|
CN |
|
NIC Autotec Inc
TSE:5742
|
JP |
|
Elis SA
PAR:ELIS
|
FR |
Cash Flow Statement
Cash Flow Statement
Changchun BCHT Biotechnology Co
Changchun BCHT Biotechnology Co
Currency: CNY
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
(122)
|
(131)
|
(126)
|
(134)
|
(103)
|
(82)
|
(71)
|
(68)
|
(78)
|
(83)
|
(86)
|
(31)
|
(65)
|
(85)
|
(140)
|
(106)
|
(66)
|
(42)
|
|
| Change in Working Capital |
(660)
|
(779)
|
(753)
|
(752)
|
(788)
|
(694)
|
(706)
|
(724)
|
(688)
|
(682)
|
(686)
|
(29)
|
(65)
|
(239)
|
(750)
|
(786)
|
(767)
|
(843)
|
|
| Cash from Operating Activities |
209
N/A
|
191
-8%
|
230
+20%
|
141
-38%
|
140
-1%
|
138
-2%
|
101
-27%
|
74
-26%
|
40
-46%
|
117
+194%
|
141
+20%
|
(3)
N/A
|
10
N/A
|
155
+1 441%
|
407
+163%
|
346
-15%
|
331
-4%
|
163
-51%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(336)
|
(381)
|
(510)
|
(627)
|
(633)
|
(552)
|
(402)
|
(200)
|
(291)
|
(302)
|
(448)
|
(30)
|
10
|
(169)
|
(542)
|
(530)
|
(470)
|
(387)
|
|
| Other Items |
2
|
0
|
121
|
(16)
|
(63)
|
(61)
|
(61)
|
5
|
2
|
(12)
|
(162)
|
0
|
1
|
1
|
1
|
(49)
|
(50)
|
(50)
|
|
| Cash from Investing Activities |
(334)
N/A
|
(378)
-13%
|
(388)
-3%
|
(643)
-66%
|
(696)
-8%
|
(613)
+12%
|
(463)
+25%
|
(195)
+58%
|
(289)
-48%
|
(314)
-9%
|
(610)
-94%
|
(18)
+97%
|
173
N/A
|
(6)
N/A
|
(541)
-8 516%
|
(579)
-7%
|
(520)
+10%
|
(437)
+16%
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
19
|
19
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(165)
|
0
|
68
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
52
|
45
|
34
|
(10)
|
82
|
110
|
157
|
234
|
|
| Cash Paid for Dividends |
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(24)
|
(41)
|
0
|
(78)
|
(1)
|
(27)
|
(27)
|
(64)
|
(64)
|
(73)
|
(74)
|
|
| Other |
339
|
341
|
1 403
|
1 398
|
1 403
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
174
N/A
|
110
-37%
|
1 474
+1 236%
|
1 402
-5%
|
1 402
+0%
|
0
N/A
|
0
N/A
|
(24)
N/A
|
(41)
-71%
|
0
N/A
|
(25)
N/A
|
44
N/A
|
26
-41%
|
(18)
N/A
|
37
N/A
|
64
+74%
|
84
+30%
|
159
+90%
|
|
| Change in Cash | |||||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
2
|
2
|
2
|
2
|
0
|
(0)
|
(0)
|
1
|
1
|
0
|
0
|
|
| Net Change in Cash |
50
N/A
|
(77)
N/A
|
1 316
N/A
|
900
-32%
|
847
-6%
|
929
+10%
|
(438)
N/A
|
(143)
+67%
|
(289)
-102%
|
(237)
+18%
|
(493)
-108%
|
23
N/A
|
209
+796%
|
130
-38%
|
(97)
N/A
|
(168)
-73%
|
(104)
+38%
|
(115)
-10%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(127)
N/A
|
(189)
-49%
|
(280)
-48%
|
(486)
-74%
|
(493)
-1%
|
(414)
+16%
|
(301)
+27%
|
(126)
+58%
|
(251)
-99%
|
(185)
+26%
|
(308)
-66%
|
(33)
+89%
|
20
N/A
|
(15)
N/A
|
(136)
-832%
|
(184)
-36%
|
(138)
+25%
|
(224)
-62%
|
|
Switch to:
Switch to:
See Also
Discover More
